Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Metacrine, Inc. (MTCR)

0.4523   0.062 (15.97%) 05-16 07:36
Open: 0.418 Pre. Close: 0.39
High: 0.466 Low: 0.41
Volume: 1,420,180 Market Cap: 19(M)
Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases. It is developing MET642, which has completed Phase I clinical trial for the treatment of ulcerative colitis. Metacrine, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.47 - 0.47 0.47 - 0.47
Low: 0.41 - 0.41 0.41 - 0.41
Close: 0.45 - 0.45 0.45 - 0.46

Technical analysis

as of: 2022-05-13 4:39:58 PM
Stoxline posted a STRONG BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 0.63     One year: 0.77
Support: Support1: 0.34    Support2: 0.29
Resistance: Resistance1: 0.54    Resistance2: 0.66
Pivot: 0.43
Moving Average: MA(5): 0.39     MA(20): 0.45
MA(100): 0.53     MA(250): 1.91
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 33.7     %D(3): 21.3
RSI: RSI(14): 47.7
52-week: High: 4.84  Low: 0.34
Average Vol(K): 3-Month: 1,699 (K)  10-Days: 837 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ MTCR ] has closed below upper band by 40.9%. Bollinger Bands are 49.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Mon, 16 May 2022
What We Must Do to Help Ukraine Win - The Dispatch

Sun, 15 May 2022
Metacrine, Inc. (NASDAQ:MTCR) Sees Large Decline in Short Interest - Defense World

Thu, 12 May 2022
IAF test-fires extended-range BrahMos from Sukhoi fighter - The Tribune India

Fri, 29 Apr 2022
Building Alliances and Competing with China - Air Force Magazine

Wed, 20 Apr 2022
IAF test fires BrahMos missile from Su-30 MKI with ‘pinpoint accuracy’ on a naval target - Frontline

Wed, 20 Apr 2022
Metacrine, Inc. (NASDAQ:MTCR) CEO Preston Klassen Sells 44748 Shares - Defense World

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 42 (M)
Shares Float 18 (M)
% Held by Insiders 18.8 (%)
% Held by Institutions 29.3 (%)
Shares Short 846 (K)
Shares Short P.Month 788 (K)

Stock Financials

EPS -2.27
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 1.77
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) -40.6
Return on Equity (ttm) -82
Qtrly Rev. Growth 0
Gross Profit (p.s.) -0.64
Sales Per Share 0
EBITDA (p.s.) -1.39
Qtrly Earnings Growth 0
Operating Cash Flow -47 (M)
Levered Free Cash Flow -26 (M)

Stock Valuations

PE Ratio -0.2
PEG Ratio 0
Price to Book value 0.25
Price to Sales 0
Price to Cash Flow -0.41

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.